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Abstract: Chronic kidney disease (CKD) is increasing in sub-Saharan Africa. Undernutrition
has been prevalent amongst end stage CKD patients, with limited data on the prevalence of
obesity. The aim of this study was to assess the nutritional status of CKD patients using various
methods sensitive to over and under-nutrition. Stage 3 to 5 CKD patients (glomerular filtration rate
(GFR) < 60 mL/min/1.73 m2) attending a pre-dialysis clinic in Cape Town, were enrolled. Exclusion
criteria included infectious and autoimmune conditions. Sociodemographic, clinical and biochemical
data were collected, and anthropometric measurements were performed. Dietary intake was measured
with a quantified food frequency questionnaire (FFQ). Statistical Package for the Social Sciences (SPSS)
version 26 was used for statistical analysis. Seventy participants, with mean age of 41.8 ± 11.8 years,
52.9% females and 47.1% males were enrolled. Participants enrolled mainly had stage 5 kidney
failure. Thirty percent were overweight (21) and 25 (36%) were obese, 22 (60%) of females were
overweight and obese, while 13 (39.4%) of males were predominantly normal weight. Abdominal
obesity was found in 42 (60%) of participants, mainly in females. Undernutrition prevalence was low
at 3%. Dietary assessment showed a high sugar and protein intake. There was a high prevalence of
overweight, obesity and abdominal obesity in CKD stage 35 patients, with unhealthy dietary intake
and other nutritional abnormalities.
Keywords: pre-dialysis nutrition assessment; nutrition assessment in chronic kidney disease;
obesity in chronic kidney disease
1. Introduction
Malnutrition in the form of overweight and obesity has been increasing in prevalence in chronic
kidney disease (CKD) [1,2]. This is likely due to the increase in chronic diseases of lifestyle, since many
are risk factors for the development of CKD [2,3]. Obesity is closely related to cardiovascular and
other metabolic diseases such as insulin resistance, type 2 diabetes mellitus and chronic inflammation
through various mechanisms [3,4]. Obesity also induces glomerular hyperfiltration [3]. An increased
body mass index (BMI) above 25 kg/m2 has recently been associated with a progressively increased
risk of CKD stages 4 to 5 [5]. It is therefore important to identify and treat obesity in early CKD to
prevent further deterioration of the disease.
CKD results in many nutritional status abnormalities as glomerular filtration rate decreases.
These include bone mineral abnormalities, anemia, inflammation, electrolyte imbalances,
undernutrition, increased catabolism and appetite problems [6,7]. This results in many dietary
restrictions. Due to the restrictive nature of the diet and due to symptoms of the disease, diet adherence
is low [8]. These factors in addition to obesity will negatively influence the nutritional status of
CKD patients.
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The International Society of Renal Nutrition and Metabolism (ISRNM) developed a set of criteria
focusing on body weight, muscle mass, biochemical assessment and dietary intake to diagnose
undernutrition, specifically in CKD patients. The Subjective Global (SGA) assessment tool has also
been used to diagnose undernutrition in CKD; however due to its subjectivity, the ISRNM suggest
that it not be used to diagnose undernutrition, but should rather be used as a clinical marker [9,10].
Neither of these have criteria for identifying overweight or obesity as a malnutrition risk.
The main focus of research has been on the high prevalence of malnutrition in terms of protein
energy undernutrition in pre-dialysis CKD patients [6,11,12]. The ISRNM criteria are used to diagnose
undernutrition in some of the studies [9]. The KoreaN cohort study for Outcome in patients With
Chronic Kidney Disease (KNOW-CKD) study reported a prevalence of 9%, while a Nigerian study
reported a prevalence of undernutrition of 47% using the ISRNM criteria, however the two studies used
the criteria in different ways [13,14]. No information was provided for the rest of the BMI categories
for either studies, although the average BMI approached the overweight category. Studies using the
SGA has also found high rates of undernutrition [1,10,15]. These studies demonstrate that different
screening criteria are used to diagnose undernutrition prevalence and that there is a failure to report
on the extent of overweight or obesity.
It is possible that less emphasis is placed on obesity because of the obesity paradox; this refers to
the reduced mortality outcomes that has been shown in CKD with higher BMI’s [16]; however there
are conflicting results particularly within the pre-dialysis patient group. Herrington et al. [5] suggests
reasons why the obesity paradox theory may not be substantiated in CKD; these include a low BMI
due to individuals being in an overall poorer health condition and often in a cachectic state, they also
suggest methodological and enrolment flaws in some of the studies reporting these associations.
This study assessed the nutritional status of CKD pre-dialysis participants using different measures
that may be sensitive to both over and undernutrition.
2. Materials and Methods
This cross-sectional study investigated the nutritional status of 70 stage 3 to 5 CKD
participants attending the pre-dialysis clinic at Tygerberg Hospital in Cape Town, South Africa,
between 1 August 2018 and 30 September 2019. Participants files were screened and were selected if
their GFR’s were less than 60 mL/min/1.73 m2 at their routine Renal Clinic visit and they were older than
18 years, provided exclusion criteria did not apply. The latter included any infectious diseases that may
affect nutritional status, immunological conditions, severe gastrointestinal disease, pregnancy, diabetes
and participants who were expected to start dialysis in the next 2 months. This study represents the
baseline data of a randomized control study investigating uraemic toxins, gut microbiome and CKD
outcomes using a prebiotic supplement. A total of 70 participants were enrolled for the study and the
baseline data is presented here.
Ethics approval was obtained (S18/03/064) from Stellenbosch University Health Research
Ethics Committee.
Data collected included socio-demographic and relevant biochemical and clinical information.
The following anthropometric measurements were performed according to World Health
Organization (WHO) standards [17]: weight (kg), height (cm), waist circumference (cm), mid-upper
arm circumference (MUAC) (cm) and triceps (mm) [18] and reported by group and gender. Appendix A
indicates the formulae used to calculate the values, reference values and interpretation.
Dietary data were collected by using a 160 item Food Frequency Questionnaire (FFQ) to evaluate
the patient’s dietary intake. It was adapted from a FFQ used in a South African study to include a
greater variety of fruits, vegetables and phosphate containing foods and was evaluated for face and
content validity [19]. It was administered by the dietitian researcher who interviewed participants.
Food models and household metric measuring instruments such as spoons and cups were used
to estimate portion sizes. Codes of the food items and the portion sizes were captured as daily
intake. It was analyzed for the macronutrient and micronutrient composition per person per day,
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the SAFOODS database was used to analyze the data [20]. The mean/median dietary intake of nutrients
were assessed and compared to the Kidney Disease Outcomes Quality Initiative (KDOQI) and Kidney
Disease Improving Global Outcomes (KDIGO) recommendations [21–23].
Adjusted oedema free body weights were used to calculate the required nutrients where values
were given per/kg of weight for energy and protein and as a percentage of energy for carbohydrate
and fats, calculated in grams per day. Values or ranges for a specific nutrient were given as per the
guidelines for cholesterol, fiber, vitamins and minerals. The nutrients were expressed as nutrient intake
below, above and within recommendations as a percentage of participants.
Patient’s barriers to eating healthy were assessed with the responses being binary: the cost of
food, time to cook or shop, motivation to cook or shop, lack of family support and the availability of
shops to purchase food.
Data were tested for normality using various methods including Kolmogorov-Smirnoff, skewness
and kurtosis values, histograms and Q-plots.
Basic descriptive tests were performed using frequencies and percentages for categorical data,
means and standard deviations for normally distributed continuous data and medians and interquartile
ranges for continuous data that was not distributed normally.
The following analytical tests were employed: correlations between protein intake and urea and
creatinine, and between energy and urea and creatinine, as well as gender differences for anthropometry
using t-tests and Chi-squared tests. Analysis of variance compared the following: BMI categories and
dietary intake, financial income and dietary intake and between GFR and age, BMI, protein and energy
intake. A p value of <0.05 was considered statistically significant.
3. Results
3.1. Socio-Demographics
Seventy participants entered the study. The mean age of the participants was 41.7 ± 11.8 years,
with a slight predominance of females (53%). Most participants were employed, earning less than
US $126 and had up to grade 11 schooling (Table 1).
3.2. Clinical
Hypertension was the most prevalent cause of renal failure and occurred in 35 (50%) of participants.
Most participants had no oedema (44, 62.9%) and 31 (44.2%) had stage 5 CKD. The mean systolic blood
pressure was 146.0 ± 25.5 mmHg and diastolic pressure was 81.0 ± 15.3 mmHg. (Table 2).
Fifty-one (73.9%) participants were receiving diuretics, 42 (60.9%) ACE inhibitors and 38 (55.1%)
calcium channel blockers. Nearly a third of participants were on calcium and iron supplements.
The majority of participants were on multiple medication combinations.
3.3. Anthropometry
Table 3 shows the mean weights which were significantly different (p = 0.03) for males and females.
Similarly, the mean triceps were higher in females than males (p = 0.001).
The mean BMI was in the overweight category for the group with no gender differences. Regarding
the BMI categories, 21 (30%) participants were overweight and 25 (36%) were obese. Obesity was
more prevalent in females, with 46% of females being obese; whereas males were mainly in the normal
weight category, with differences in gender being statistically significant (Chi2 = 8.9, p = 0.03) (Table 3).
The mean MUAC for the group was in the obese category, with no gender differences.
The prevalence of underweight in this study was 4.3%, with only 3% of participants also having a
wasted muscle and fat mass.
The majority of participants had a waist circumference in the high risk for chronic diseases
category; this group comprised predominantly of females (57%), whereas males were in the normal
waist category. The gender differences in waist circumference was significant (Chi2 = 8.0, p = 0.005).
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Thirty six (51.4%) of participants, had average arm muscle evenly spread between gender, and 40 (57.1%)
also had average arm fat, with a significant gender differences between AFA categories (Chi2 = 12.2.0,
p = 0.02).
Table 1. Sociodemographic profile of participants.
n Mean ± SD






Full time 29 41.4
Part time 5 7.1
Unemployed 22 31.4
Pensioner/Grant holder 4 5.7
Other 10 14.2
Monthly Income
US $0–126 29 41.4
US $127–316 18 25.7
US $317–633 15 21.4
US $634–949 5 7.1
>US $949 3 4.3
Education level
Primary school 10 14.3
Grade 8–11 32 45.7
Grade 12 20 28.6
University 1 1.4
Technicon 7 10.0
Table 2. Clinical data of participants.
n Mean ± SD
Blood pressure (systolic) mmHg 64 146.0 ± 25.5








Stage 3 21 30.0
Stage 4 18 25.7
Stage 5 31 44.2
Cause Renal Failure
Polycystic kidney disease 6 8.6
Hypertension 35 50.0
Glomerular disease 13 18.6
Other and unknown 16 22.9
GFR: Glomerular filtration rate.
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n = 37 * p Value
Mean ± SD
Weight (kg) 76.8 ± 25.4 82.9 ± 23 71.4 ± 19.7 * 0.03
BMI (unit) 28.4 ± 7.0 28.4 ± 7.8 28.6 ± 6.4 * 0.90
Waist circumference (cm) 92.1 ± 16.8 94.9 ±19.5 91.6 ± 13.7 * 0.18
MUAC (cm) 31.0 ± 5.4 31.2 ± 5.1 30.5 ± 5.8 * 0.84
Triceps (mm) 21.0 ± 9.1 17.0 ± 9.0 24.0 ± 8.0 * 0.001
BMI Categories n (%)
Underweight 3 (4.3) 0 3 (8.1)
Chi2 = 8.9, p = ** 0.03
Normal weight 21 (30.0) 13 (39.4) 8 (21.7)
Overweight 21 (30.0) 12 (36.4) 9 (24.3)
Obese 25 (35.7) 8 (24.2) 17 (45.9)
Waist circumference
Categories
Normal 28 (40) 18 (54.5) 10 (27.0)
Chi2 = 8.0, p = ** 0.005Increased risk 13 (18.6) 7 (21.2) 6 (16.2)
High risk 29 (41.4) 8 (24.2) 21 (56.8)
MUAC Categories n (%)
Undernourished 5 (7.1) 0 5 (13.5)
Chi2 = 3.0, p = ** 0.22
Normal 17 (24.3) 9 (27.2) 8 (21.6)
Overweight 9 (13.0) 5 (15.1) 4 (10.8)
Obese 39 (55.7) 19 (57.5) 20 (54.0)
AMA Categories n (%)
Wasted 1 (1.4) 1 (3.0) 0
Chi2 = 8.9, p = ** 0.06
Below average muscle 7 (10.0) 6 (18.2) 1 (2.7)
Average muscle 36 (51.4) 17 (51.5) 19 (51.4)
Above average muscle 13 (18.6) 5 (15.2) 8 (21.6)
High muscle 12 (17.1) 3 (9.1) 9 (24.3)
AFA Categories n (%)
Wasted 5 (7.1) 3 (9.1) 2 (5.4)
Chi2 = 12.2, p = ** 0.02
Below average fat 5 (7.1) 1 (3.0) 4 (10.8)
Average fat 40 (57.1) 18 (54.5) 22 (59.5)
Above average fat 10 (14.3) 2 (6.1) 8 (21.6)
Excess fat 9 (12.9) 8 (24.2) 1 (2.7)
* Independent t-tests. ** Chi-squared tests. BMI: body mass index; MUAC: mid upper arm circumference; AMA:
arm muscle area; AFA: arm fat area.
3.4. Dietary Intake
Table 4 describes the mean/median intake of macronutrients and micronutrients and how they
compare to recommended KDOQI ranges. The mean energy intake was 27 kcal per kg which is
within the guidelines. The mean protein intake was higher than the guidelines at 1 g/kg, specifically
animal protein at 64.8% of protein intake. Saturated fat intake was higher than guidelines at 10.7%.
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Added sugar and total sugar intake was high at 39 g and 70 g respectively. The mean intake of all other
minerals and vitamins were within the recommendations, except for folate and vitamin D, which were
lower than the guidelines.






Energy kcal/kg 25–35 [23] 27
2041.7 ± 732 kcal/kg
Total protein g/kg 0.6–0.8 1
0.55–0.6 g/kg [23] 74.2 ± 28.4 g
Plant protein 50% of protein intake 34.2%
25.4 ± 10.7 g
Animal protein 50% of protein intake 64.8%
48.1 ± 21.2 g
Total fat 34% Energy
35.2%
80.0 ± 34.9 g
Saturated Fat <7% of Energy
10.7%
24.3 ± 11.7 g
Monounsaturated Fat <20% Energy
12.2%
27.7 ± 14.4 g
Polyunsaturated Fat <10% Energy 9.0%20.6 ± 8.6 g
Total trans fat g 0 0.7 ± 0.5
Cholesterol mg 200–300 278.2 ± 133.7
Carbohydrate 55% Energy 49.3% E251.9 ± 93.7 g
Added sugar g 25 39.1 (23.0, 59.1) *
Total sugars g NA 69.9 ± 29.2
Total dietary fiber g 253–0 21.8 ± 9.7
Calcium mg 1000–1200 484.7 (349.0, 743.1) *
800–1000 [23]
Iron mg 101–8 13.0 ± 4.6
Phosphate mg 800–1000 1038.7 ± 420.6
Sodium mg 2400 2049 ± 965.12300 [23]
Potassium mg 2000–3000 2691.2 ± 932.7
Vitamin B6 mg 5 3.2 ± 1.3
Folate mg 1000 291.8 ± 118.0
Vitamin D mg 5–10 2.7 (1.8, 5.2) *
All values given as a mean SD, except as * median (interquartile range). Values calculated where g/kg of a nutrient
is given or as range. Updated KDOQI guidelines were recently released: the reference [23] indicates where they
differ, for the rest of the values, no specific values were provided in the update, it is therefore based on previous
guidelines. NA, not applicable.
Barriers such as cost of food were prevalent in 63% of patients, and 25% of patients lacked
motivation to shop or cook.
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We compared the intake of nutrients to dietary recommendations and grouped them according
to the following criteria: within, more than or less than the recommended guidelines. (Figure 1).
The following nutrients were consumed in quantities higher than the recommendations in more than
50% of participants: saturated fat, added sugar, trans fats, animal protein and total protein.
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The median CRP was higher than the cut-off range and inflammation was present in 42 (60%) of
participants. (Table 5) GFR categories (stage 3, 4 and 5) were compared to various variables, including
age, BMI, waist, MUAC, protein and energy intake, with no significant differences found. Even though
the BMI of those with stage 4 and 5 kidney failure were higher than those in Stage 3 kidney failure,
the difference was not significant (p = 0.3). Similarly, waist circumference was also 8 cm higher in
stage 4 than stage 3, also not statistically significant (p = 0.2). As expected, biochemical values were
significantly higher for urea (p < 0.01), creatinine (p < 0.01), phosphate (p < 0.01) and potassium
(p = 0.03) in stage 5 compared to stage 3 kidney failure due to the more advanced stage of the disease.
Table 5. Biochemistry profile of participants.
Normal Ranges * Actual Median andInterquartile Range
Urea mmol/L 2.1–7.1 16.3 (10.9, 25.3)
Creatinine umol/L 64–104 287.0 (183, 477.5)
GFR mL/min·1.73 m2 >60 19.0 (10.8, 31.2)
Potassium mmol/L 3.5–5.1 4.8 (4.3, 5.2)
Sodium mmol/L 136–141 142.0 (139, 144.0)
Phosphate mmol/L 0.78–1.42 1.4 (1.1, 1.5)
Total Chol mmol/L (high risk) <4.5 4.9 (3.9, 5.7)
LDL (high risk) mmol/L <2.6 ** 2.7 (2.1, 3.3)
HDL mmol/L >1.2 1.1 (1.0, 1.4)
TG mmol/L <1.7 1.7 (1.2, 2.5)
CRP mg/L <3 ** 5.0 (1, 9)
* Normal ranges used by the South African National Health Laboratory (NHLS). ** Inflammation defined as a
CRP > 3 mg/dL [13]. ** According to the American College of Cardiology CKD stage 3 and 4 is considered high
risk for artherosclerotic cardiovascular disease [24]; GFR: glomerular filtration rate; Total Chol: Total cholesterol;
LDL:Low-density lipoprotein, HDL: High density lipoprotein, TG: Triglycerides; CRP: C-reactive protein.
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4. Discussion
The aim of this study was to assess the nutritional status of pre-dialysis CKD patients. We found
a high prevalence overweight, obesity and abdominal obesity, low rates of undernutrition, and an
unhealthy diet.
The mean age of the participants were 41.7 years, which is younger than most other CKD studies.
In contrast to older studies [14,15], almost two thirds of participants were overweight or obese;
45% of females were predominantly obese. Abdominal obesity was present in 60% of participants,
again predominantly in females. The BMI and waist circumference were higher in stage 4 and 5 CKD.
Chan et al. [1], similarly to our study showed 62.4% of participants were overweight and obese, whereas
Dierkes et al. [2] found an overweight and obesity prevalence of 65%. They also found a high rate of
central obesity in 53% of patients. Epidemiological studies have also shown high prevalence of CKD in
overweight and obese patients with higher BMIs in CKD stages 4–5 [5,16]. The high prevalence of
overweight and obesity could relate to the high prevalence in the general population in South Africa in
which 68% of women and 31% of men are overweight or obese [25]. The prevalence found in this study
is similar to that of the background South African population in women, but there is a much higher
prevalence of overweight and obesity in CKD men in this study. Most of these patients may have
already been overweight and obese at diagnosis of CKD. This emphasizes the importance of weight
control during the early stages of kidney disease to prevent further deterioration of the disease [3].
A majority of participants in the study had high arm muscle and high fat area which could relate to
the increased BMI as other studies have shown [26,27]. Triceps and MUAC measurements were higher
than reported [1,15,28] Muscle wasting was not found in obese participants in this study. Chan et al. [1],
found a high rate of malnutrition including muscle wasting in their overweight and obese participants
based on the SGA. The malnutrition was more significant as the age increased [1]. Dierkes et al. [2]
also found a high rate of sarcopenia and sarcopenic obesity in their study, which also increased with
age. Body composition changes associated with aging include increased fat mass and reduced muscle
mass [2].
A possible explanation for the lack of muscle wasting and sarcopenia is this study is that the
participants were much younger with an average age of 41 than the participants in both of the other
studies, who averaged 65 years of age.
Hypertension was the most prevalent cause of CKD in participants as documented by the
clinicians; this was similar to other studies and is also reflective of the hypertension rates in South
Africa, where hypertension is present in 45% of men and 44% of women [13,14,25]. Overweight and
obesity can account for 65–75% of the risk for hypertension [3]. Renal sinus fat have been associated
with hypertension and the need for more hypertensive medications [3] The blood pressure was slightly
higher in this study than recommended in CKD participants despite being on various combinations
of anti-hypertensive medications. Hypertension together with other disorders linked to metabolic
syndrome such as the obesity shown in this study can act synergistically to increase the risk for CKD
and end stage kidney failure (ESKF). Sodium intake was lower than recommendations in a majority of
participants. Sodium has been linked to hypertension and fluid retention.
Undernutrition in CKD has been a serious feature of CKD participants whereas obesity has
received less attention due to the obesity paradox concept. Recent studies still show a high prevalence
of undernutrition in some populations [1,14,15]. However, these studies use the criteria differently,
leading to varying results. When the criteria used in the ISRNM were applied in our study, i.e.,
total cholesterol <100 mg, BMI <23 kg/m2 and dietary protein intake <0.6 g/kg, the prevalence of
undernutrition was found to be zero. However, there were participants that were underweight as well
as having wasted arm muscle mass and fat. The overall rate of undernutrition was therefore very low
in this study and mainly confined to underweight participants with a wasted muscle and fat arm area
which affected only 3% of participants. This is similar to that reported by Dierkes et al [2] who only
found malnutrition in 3% using a nutritional risk score.
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The dietary intake was indicative of unhealthy food choices, which is typical of a Western
dietary food pattern. This study differs from others in terms of energy intake: 30% were higher than
recommended range, while 32% were lower and 34% were in the normal range. Wlodarek et al. [29]
reported that as many as 93% of their participants consume less energy than recommended.
Steiber et al. [30] showed only 15% of participants met 75% of their requirements. Energy intake did
not differ significantly amongst the BMI or GFR categories. A quarter of obese participants in this
study were taking an average energy intake of 14 kcal/kg which may reflect underreporting. The latter
is a common finding in obese patients [31]. The KDOQI energy requirement for obese participants
are 303–305 kcal/kg [21]. More recent guidelines have advised 253–255 kcal/kg based on age, sex,
activity level and body weight goals [23]. The lower energy recommendation of 25 kcal/kg should be
recommended for overweight and obese subjects.
Protein intake was higher than recommended in 67% of participants and consisted mostly of animal
protein. A protein intake of 0.60–0.8 g/kg has been recommended in CKD pre-dialysis participants;
levels of 0.8 g/kg has been found to prevent a negative nitrogen balance together with a sufficient
energy intake [32]. The most recent KDOQI guidelines suggest a protein intake of 0.550–0.6g/kg per
day [23]. The high protein intake in most participants in this group differs from other studies, where
intakes were reported to be mainly lower than recommended. A high protein intake is associated with
a more rapid decline in kidney function and other complications [33]. This high intake of protein could
also be reflective of the higher energy intake in some participants.
Protein intake did not differ in the GFR categories but was found to be significantly higher in
participants with a higher income. Protein is often the most expensive food item when shopping,
with processed protein sources being cheaper. The cost of food was found to be a barrier to purchasing
healthy food options in this study. Although the average income was low, the animal protein intake
was surprisingly high in this study. A low income increases the risk of disorders that predispose CKD
progression and worsens outcomes in those who already have CKD [34]. Socio-economic factors are
important to consider in CKD management. A majority of participants did not complete high school,
a lower level of education has been associated with decreased adherence behavior in CKD due to lower
health literacy [34].
The high animal protein intake could explain why dietary saturated fat intake and cholesterol
intake were higher than recommended ranges, as well as why the total and LDL cholesterol levels were
raised. Few participants were using statins. Although total fat is within the recommended ranges,
the intake of healthier fats such as polyunsaturated and monounsaturated fat should be favored.
These intakes were lower than recommendations for most participants.
Although the fiber intake was low for the most participants, the mean intake was good and
marginally higher than reported in other studies [1,29]. Fiber intake is usually low in CKD participants
due to dietary restrictions of wholegrains, fruit and vegetables. A high fiber intake has recently
been found to reduce uraemic toxins and subsequently improve the gut microbiome in CKD [35].
Fiber regulates the bacteria in the gut and enhances the growth of saccharolytic bacteria [36]. These are
essential as fuel cells for the colonic epithelial cells and regulatory T lymphocytes. These cells are
already reduced in renal failure and this, together with a low fiber diet, may account for CKD-associated
systemic inflammation [37]. Inflammation was high in this study, and it is usually associated with
adverse outcomes such as increased mortality, progression of disease, increased cardiovascular disease,
muscle wasting and cognitive decline [38].
Participants in this study had a very high sugar intake. Excessive intake of refined sugar can
increase triglycerides and contribute to obesity. A recent review of refined sugars in CKD indicates
that it is a driver of kidney disease and its consequences by causing metabolic derangements such as
insulin resistance and uric acid production. This increases the conversion of glucose to fructose via the
polyol pathway; this pathway has recently been implicated to cause kidney damage [39].
Phosphate intake was high in a larger percentage of participants, and calcium and vitamin D
levels were low. Vitamin D intake is generally low in the general population and even more so in CKD
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participants [40]. A high phosphate intake was found in nearly half of the participants. High phosphate
levels have been associated with increased cardiovascular disease due to vascular calcification as well as
increased mortality [41]. Mineral and vitamin intake also varied. The low intake of folate and vitamin
B6 intake are concerning since they are co-factors of homocysteine metabolism. Hyperhomocystenemia
can contribute to cardiovascular disease, which is already a high risk in CKD participants [42]. Only a
few participants were on a folate supplement and folate intake was lower than recommendations in all
participants. Most participants had an adequate intake of other vitamins and minerals.
Limitations of Study
There are various dietary intake assessment tools including 24-h recalls, food records and food
frequency questionnaires, which are each subject to strengths and limitations. Although highly
accurate data can be obtained with a food frequency questionnaire, measurement errors related to
the methodology remain [43]. The relatively small sample size and strict exclusion criteria may have
limited the inclusion of older participants. For muscle mass assessment, bio-electrical impedance
measures and 24-h urine creatinine excretion may have given more accurate results, however this was
not done due to resource limitations. Hypertension as a cause of CKD has been challenged, however
we relied on the diagnosis that clinicians had recorded in the medical notes. Without renal biopsies
being documented, it may be that hypertension was not the most prevalent cause of CKD.
5. Conclusions
This study set out to determine the nutritional status of CKD patients and found a variety of
factors, both from a medical and social perspective predisposed this younger study population to
CKD development and increased risk of cardiovascular disease. These factors include hypertension,
inflammation, obesity, dietary, socioeconomic and education factors.
Obesity was highly prevalent, with a low prevalence of undernutrition. Dietary evaluation
showed an unhealthy Western dietary pattern. The standard nutrition assessment methods gave a
good overall impression of the nutritional status of patients.
Nutrition advice should also aim to improve the diet to a healthier pattern and target nutrition
supplementation such as folate, calcium and vitamin D with more emphasis on obesity management
such as stricter dietary recommendations, physical activity guidelines and behavior modification
for weight loss. Medical and surgical options should be considered to treat more advanced obesity.
A multi-faceted approach should be employed to deal with the disparities that predispose the population
to the development of CKD as well as improving outcomes in those with CKD. On a population wide
level, efforts should be employed to reduce the high prevalence of obesity, hypertension and other
chronic conditions to prevent the development of CKD.
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Appendix A
Table A1. Anthropometric Measurements and Interpretations.
Measurement Formula Cut-Off Values Interpretation
BMI [17] Weight/height2 <18.49 kg/m2 underweight





aBWef= BWef + [(SBW − BWef) × 0.25]
ef: oedema free weight
MUAC [45]
<23 cm females Malnourished
<22 cm males Malnourished
>28 females Overweight
>29 males Overweight
>30 females and males Obese
WC [46] <80 cm for females
<94 cm for males Normal




Increased risk for disease
>88 cm for females and
>102 cm for males High risk for disease
AFA/AMA
area [44]
AFA = [MAC(cm) × TSF(cm)/2 π ×
TSF(cm)2]/4 π <5th percentile Wasted
AMA = [MAC (cm) − (π × Triceps










>95th percentile High muscle/fat
BMI: Body mass index; MUAC: Mid upper arm circumference; WC: Waist circumference; AFA: Arm fat area; AMA:
Arm muscle area.
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